{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:52:46Z","timestamp":1783745566549,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00198-023-06669-y","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T12:02:32Z","timestamp":1673697752000},"page":"999-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["DXA-based bone strain index in normocalcemic primary hyperparathyroidism"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-0700","authenticated-orcid":false,"given":"Gaia","family":"Tabacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4576-3381","authenticated-orcid":false,"given":"Anda Mihaela","family":"Naciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rinaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cesareo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-3425","authenticated-orcid":false,"given":"Fabio Massimo","family":"Ulivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-4926","authenticated-orcid":false,"given":"Andrea","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,14]]},"reference":[{"issue":"10","key":"6669_CR1","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D\u2019Amour P, Shoback DM, Thakker RV (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab 99(10):3570\u20133579","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6669_CR2","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1210\/clinem\/dgaa084","volume":"105","author":"M Schini","year":"2020","unstructured":"Schini M, Jacques RM, Oakes E, Peel NFA, Walsh JS, Eastell R (2020) Normocalcemic hyperparathyroidism: study of its prevalence and natural history. J Clin Endocrinol Metab 105(4):e1171\u2013e1186","journal-title":"J Clin Endocrinol Metab"},{"key":"6669_CR3","doi-asserted-by":"publisher","unstructured":"Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D et al (2020) Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab 105(7):dgaa174. https:\/\/doi.org\/10.1210\/clinem\/dgaa174","DOI":"10.1210\/clinem\/dgaa174"},{"issue":"10","key":"6669_CR4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.eprac.2021.04.884","volume":"27","author":"AM Naciu","year":"2021","unstructured":"Naciu AM, Tabacco G, Falcone S, Incognito GG, Chiodini I, Maggi D et al (2021) Bone quality as measured by trabecular bone score in normocalcemic primary hyperparathyroidism. Endocr Pract 27(10):992\u2013997","journal-title":"Endocr Pract"},{"key":"6669_CR5","unstructured":"Tecnologie Avanzate - Bone Strain Index.\u00a0https:\/\/www.tecnologie-avanzate.com\/ricerca-e-sviluppo\/bone-strain-index. Accessed\u00a012 Jan 2023"},{"key":"6669_CR6","doi-asserted-by":"publisher","unstructured":"Ulivieri FM, Rinaudo L (2021) Beyond bone mineral density: a new dual X-ray absorptiometry index of bone strength to predict fragility fractures, the bone strain index. Front Med (Lausanne) 7:590139. https:\/\/doi.org\/10.3389\/fmed.2020.590139","DOI":"10.3389\/fmed.2020.590139"},{"issue":"6","key":"6669_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/hae.13611","volume":"24","author":"FM Ulivieri","year":"2018","unstructured":"Ulivieri FM, Rebagliati GAA, Piodi LP, Solimeno LP, Pasta G, Boccalandro E et al (2018) Usefulness of bone microarchitectural and geometric DXA-derived parameters in haemophilic patients. Haemophilia 24(6):980\u2013987","journal-title":"Haemophilia"},{"issue":"1","key":"6669_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11657-018-0507-8","volume":"13","author":"G Rodari","year":"2018","unstructured":"Rodari G, Scuvera G, Ulivieri FM, Profka E, Menni F, Saletti V et al (2018) Progressive bone impairment with age and pubertal development in neurofibromatosis type I. Arch Osteoporos 13(1):93","journal-title":"Arch Osteoporos"},{"issue":"1","key":"6669_CR9","doi-asserted-by":"publisher","first-page":"e0190477","DOI":"10.1371\/journal.pone.0190477","volume":"13","author":"FM Ulivieri","year":"2018","unstructured":"Ulivieri FM, Piodi LP, Grossi E, Rinaudo L, Messina C, Tassi AP et al (2018) The role of carboxy-terminal cross-linking telopeptide of type I collagen, dual x-ray absorptiometry bone strain and Romberg test in a new osteoporotic fracture risk evaluation: a proposal from an observational study. Chung CK, ed. PLoS ONE 13(1):e0190477","journal-title":"PLoS ONE"},{"key":"6669_CR10","doi-asserted-by":"publisher","unstructured":"Messina C, Rinaudo L, Cesana BM, Maresca D, Piodi LP, Sconfienza LM et al (2020) Prediction of osteoporotic fragility re-fracture with lumbar spine DXA-based derived bone strain index: a multicenter validation study. Osteoporos Int\u00a032(1):85\u201391. https:\/\/doi.org\/10.1007\/s00198-020-05620-9","DOI":"10.1007\/s00198-020-05620-9"},{"issue":"8","key":"6669_CR11","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1210\/clinem\/dgab317","volume":"106","author":"G Tabacco","year":"2021","unstructured":"Tabacco G, Naciu AM, Messina C, Sanson G, Rinaudo L, Cesareo R et al (2021) DXA-based bone strain index: a new tool to evaluate bone quality in primary hyperparathyroidism. J Clin Endocrinol Metab 106(8):2304\u20132312","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6669_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3803\/EnM.2021.1061","volume":"36","author":"G Zavatta","year":"2021","unstructured":"Zavatta G, Clarke BL (2021) Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach. Endocrinol Metab (Seoul, Korea) 36(3):525\u2013535","journal-title":"Endocrinol Metab (Seoul, Korea)"},{"issue":"3","key":"6669_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11914-020-00574-7","volume":"18","author":"L Rejnmark","year":"2020","unstructured":"Rejnmark L, Ejlsmark-Svensson H (2020) Effects of PTH and PTH hypersecretion on bone: a clinical perspective. Curr Osteoporos Reports 18(3):103\u2013114","journal-title":"Curr Osteoporos Reports"},{"issue":"7","key":"6669_CR14","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1210\/jc.2013-1300","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Maalouf NM, Wang PY, Zhang C, Cremers SC, Haney EM et al (2013) Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 98(7):2734\u20132741","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6669_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94(2):351\u2013365","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"6669_CR16","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1210\/jc.2002-021404","volume":"88","author":"G Maruani","year":"2003","unstructured":"Maruani G, Hertig A, Paillard M, Houillier P (2003) Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 88(10):4641\u20134648","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06669-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06669-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06669-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:02:13Z","timestamp":1681448533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06669-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,14]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6669"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06669-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,14]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C. Messina, G. Sanson, S. Falcone, and F.M. Ulivieri disclosed no conflict of interest; G Tabacco disclosed lecture fees from Amgen; L. Rinaudo was put in charge of the BSI project by Tecnologie Avanzate s.r.l.; A.M. Naciu and R. Cesareo disclosed lecture fees from Amgen and Bruno Farmaceutici; N. Napoli disclosed consultant for Lilly, Abiogen, and UCB; A. Palermo disclosed lecture fees from Amgen and Abiogen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}